<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-sub-section" /><meta name="keywords" content="Hypomagnesaemia; Magnesium glycerophosphate; Torsade de pointes: magnesium sulphate; Magnesium sulphate: arrhythmias; Magnesium sulphate: torsade de pointes; Torsade de pointes; Myocardial infarction: management: magnesium sulphate; Magnesium sulphate: myocardial infarction; Magnesium sulphate: arrhythmias; Magnesium sulphate: eclampsia; Pre-eclampsia: magnesium in; Eclampsia" /><meta name="IX" content="Hypomagnesaemia; Magnesium glycerophosphate; Torsade de pointes: magnesium sulphate; Magnesium sulphate: arrhythmias; Magnesium sulphate: torsade de pointes; Torsade de pointes; Myocardial infarction: management: magnesium sulphate; Magnesium sulphate: myocardial infarction; Magnesium sulphate: arrhythmias; Magnesium sulphate: eclampsia; Pre-eclampsia: magnesium in; Eclampsia" /><title>9.5.1.3 Magnesium: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="5058.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="5058.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=5058.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2076.htm">9 Nutrition and blood</a> &gt; <a href="5028.htm">9.5 Minerals</a> &gt; <a href="5029.htm">9.5.1 Calcium and magnesium</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="129072.htm" title="Previous: CINACALCET">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="33361.htm" title="Next: MAGNESIUM SULPHATE">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_5058">9.5.1.3 Magnesium</h1><?highlighter on?><div id="pC" class="jN"><div><p>Magnesium is an essential constituent of
many enzyme systems, particularly those involved in energy generation;
the largest stores are in the skeleton.</p><p><span>Magnesium salts</span> are not well absorbed from
the gastro-intestinal tract, which explains the use of <span>magnesium
sulphate</span> (<a title=" Osmotic laxatives" href="2237.htm#_2237">section 1.6.4</a>) as an osmotic laxative.</p><p>Magnesium is excreted mainly by the kidneys and is therefore
retained in renal failure, but significant <i>hypermagnesaemia</i> (causing muscle weakness and arrhythmias) is rare.</p><div id="_201292"><div class="cAZ"><h2>Hypomagnesaemia</h2> <p class="cAX">Since magnesium is secreted in large amounts in the gastro-intestinal
fluid, excessive losses in diarrhoea, stoma or fistula are the most
common causes of <i>hypomagnesaemia</i>; deficiency may
also occur in <span>alcohol</span>ism or as a result of treatment
with certain drugs. <span id="_5058.2">Hypomagnesaemia often causes secondary hypocalcaemia, and also hypokalaemia
and hyponatraemia.</span></p><p><span id="_5058.3">Symptomatic <i>hypomagnesaemia</i> is associated with a
deficit of 0.5–1 mmol/kg; up to 160 mmol Mg<sup>2+</sup> over up to
5 days may be required to replace the deficit (allowing for urinary
losses). Magnesium is given initially by intravenous infusion or by
intramuscular injection of <b><span>magnesium sulphate</span></b>; the intramuscular injection is painful. Plasma
magnesium concentration should be measured to determine the rate and
duration of infusion and the dose should be reduced
in renal impairment.</span> To prevent <i>recurrence of
the deficit</i>, magnesium may be given by mouth in a dose of
24 mmol Mg<sup>2+</sup> daily in divided doses; suitable preparations
are magnesium glycerophosphate tablets or liquid [unlicensed], available
from <a title="appendix: Special-order Manufacturers" href="106216.htm#_106216">‘special-order’ manufacturers or specialist importing
companies</a>. For maintenance (e.g. in
intravenous nutrition), parenteral doses of magnesium are of the order
of 10–20 mmol Mg<sup>2+</sup> daily (often about 12 mmol Mg<sup>2+</sup> daily).</p></div></div><div id="_201294"><div class="cAZ"><h2>Arrhythmias</h2> <p class="cAX"><span>Magnesium sulphate</span> injection has also been recommended for the emergency treatment
of <i>serious arrhythmias</i>, especially in the presence
of hypokalaemia (when hypomagnesaemia may also be present) and when
salvos of rapid ventricular tachycardia show the characteristic twisting
wave front known as <i>torsade de pointes</i> (see also <a title="sub-section: Management of arrhythmias" href="2409.htm#_2409">section 2.3.1</a>). The usual intravenous dose
of <span>magnesium sulphate</span> injection is 8 mmol Mg<sup>2+</sup> (2 g) over 10–15 minutes (repeated once if necessary).</p></div></div><div class="cAZ"><h2>Myocardial infarction</h2> <p class="cAX">Limited evidence
that magnesium sulphate prevents arrhythmias and reperfusion injury
in patients with suspected myocardial infarction has not been confirmed
by large studies. Routine use of magnesium sulphate for this purpose
is not recommended. For the management of myocardial infarction, see <a title="sub-section: Management of myocardial infarction" href="60552.htm#_60552">section 2.10.1</a>.</p></div><div id="_5058.1"><div class="cAZ"><h2>Eclampsia and pre-eclampsia</h2> <p class="cAX"><span>Magnesium sulphate</span> injection is the drug of choice
for the treatment of seizures and the prevention of recurrent seizures
in women with <i>eclampsia</i>. Regimens may vary between
hospitals. Calcium gluconate injection is used for the management
of magnesium toxicity.</p><p>Magnesium sulphate injection is also of benefit
in women with <i>pre-eclampsia</i> in whom there is concern
about developing eclampsia. The patient should be monitored carefully
(see under <a title="monograph: MAGNESIUM SULPHATE" href="33361.htm#_33361">Magnesium Sulphate</a>).</p></div></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_33361"><a href="33361.htm" title="MAGNESIUM SULPHATE">MAGNESIUM SULPHATE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="129072.htm">Previous: CINACALCET</a> | <a class="top" href="5058.htm#">Top</a> | <a accesskey="]" href="33361.htm">Next: MAGNESIUM SULPHATE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>